Novo Nordisk will target launches of its popular obesity shot Wegovy in markets where it already has strong sales of its older weight-loss drug Saxenda, CEO Lars Fruergaard.
Novo Nordisk will more than double supplies of lower doses of its obesity drug Wegovy in the United States compared with recent months, CEO Lars Fruergaard Jorgensen said on.
Youth with overweight or obesity may benefit from mental health screening and lifestyle intervention programs, report researchers who found patterns of mental health comorbidity.
Dancing is an effective fat-burner, new research shows. It’s also fun, free, and you don’t even have to leave the house. Here’s how to encourage your patients to give it a whirl.
Germany's health ministry has no plans to change a law that prevents the health insurance system from paying for weight-loss drugs, it said on Tuesday, dismissing remarks by.